-
admin
Posts
Shengsi Hosts the 4th Ocean Games in Zhejiang Province
ZHOUSHAN, China, June 14, 2024 /PRNewswire/ — This summer, the 4th Zhejiang Ocean Games were grandly held on the picturesque island of Shengsi, attracting over...
China has been the most firmly and actively committed to promoting peace talks on the Ukraine issue
BEIJING, June 15, 2024 /PRNewswire/ — A Report from People’s Daily: The Ukraine crisis has shown no sign of stopping and generated more spillovers. The...
YOFC and China Mobile Debut World’s First 800G Hollow-Core Fibre Transmission Network
WUHAN, China, June 15, 2024 /PRNewswire/ — On June 6, Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), in collaboration with China Mobile, unveiled...
Fashion Forward Fusion: The Pearl Source Introduces Statement Pearl Earrings, Merging Classic Style with 2024 Trends
Los Angeles, June 14, 2024 (GLOBE NEWSWIRE) — Los Angeles, California – Jewelry Alchemy – Where Timeless Sophistication Meets Trending Designs The Pearl Source, renowned...
Cornerstone Cabinetry: Remodeling Contractors Launches a Line of Top-Quality On-Demand Products
Des Moines, June 14, 2024 (GLOBE NEWSWIRE) — Des Moines, Iowa – With its line of Cornerstone Cabinetry, Remodeling Contractors is revolutionizing the remodeling industry...
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance
MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), reports that it has received an official notice...
ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
SAN MATEO, Calif. and SINGAPORE, June 14, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (“ASLAN” or the “Company”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing...
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 14, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing...
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and research. PAIN is the...